These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5987407)

  • 1. [Is the vasoconstrictor test suitable for comparing the effect of locally applied corticosteroids? An experimental study].
    Zaun H
    Arch Klin Exp Dermatol; 1966; 226(4):359-68. PubMed ID: 5987407
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoconstrictor potency of corticoids: intradermal injection.
    Sutton PM; Feldmann RJ; Maibach HI
    J Invest Dermatol; 1971 Dec; 57(6):371-6. PubMed ID: 5127971
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of topically applied corticosteroids and zinc on the metallothionein content of skin in an experimental model.
    Frings MM; Kind PP; Goerz G; Abel J
    Clin Exp Dermatol; 1989 Nov; 14(6):434-6. PubMed ID: 2605806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMPARATIVE VASOCONSTRICTOR ACTIVITIES OF CORTICOSTEROIDS APPLIED TOPICALLY.
    HESELTINE WW; MCGILCHRIST JM; GARTSIDE R
    Br J Dermatol; 1964 Feb; 76():71-3. PubMed ID: 14119264
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
    Snyder DS; Greenberg RA
    J Invest Dermatol; 1974 Dec; 63(6):461-3. PubMed ID: 4430856
    [No Abstract]   [Full Text] [Related]  

  • 6. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE].
    SIMONS RD
    Hautarzt; 1964 Jun; 15():287-94. PubMed ID: 14234732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of dermatocorticoids (2. Continuation)].
    Weirich EG
    Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
    [No Abstract]   [Full Text] [Related]  

  • 9. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects and side effects of corticosteroids in allotransplantation].
    Klaue P
    Fortschr Med; 1976 Mar; 94(9):491-500. PubMed ID: 786840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth inhibition of clonal osteosarcoma cell-lines by low concentrations of glucocorticoid hormones.
    Eilam Y; Silbermann M; Szydel N
    Biochem Biophys Res Commun; 1980 Sep; 96(1):299-305. PubMed ID: 6933991
    [No Abstract]   [Full Text] [Related]  

  • 13. Extemporaneous formulation of corticosteroids for topical usage.
    Burdick KH; Poulsen B; Place VA
    JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the external use of triamcinolone acetonide under foil occlussive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol].
    Hartmann F; Lahmann JJ
    Hautarzt; 1977 Apr; 28(4):198-202. PubMed ID: 559653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glucocorticoids on estrogen-dependent luteinizing hormone release in the ovariectomized rat and on gonadotropin secretin in the intact female rat.
    Baldwin DM
    Endocrinology; 1979 Jul; 105(1):120-8. PubMed ID: 376294
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid-mediated establishment of an antiviral state coincident with other glucocorticoid-induced biochemical activities in L929 cells.
    Lancz GJ; Hulick BA; Grasso RJ; Skinner L
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2249-52. PubMed ID: 2864388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depigmenting action of corticosteroids. Experimental study on guinea pigs.
    Arnold J; Anthonioz P; Marchand JP
    Dermatologica; 1975; 151(5):274-80. PubMed ID: 1225665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 19. Corticosteroid-induced dermal atrophy in the rat.
    Young JM; Yoxall BE; Wagner BM
    J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.